The [natCu]PDC-1 treatment resulted in prolonged survival ofmice bearing αvβ6 (+) tumors (mediansurvival: 77 days, vs αvβ6 (−)tumor group 49 days, and all other control groups 37 days). The gene discussed is PDC; the disease is neoplasm.